Q2 2025 Management View CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Leeford is shaping the future of healthcare through cutting-edge formulations and a commitment to global quality standards.

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

Nepal Ausadhi Limited has been awarded with the Good Manufacturing Practice (GMP) certificate, meeting the World Health ...

Dr Agarwal IPO opened for subscription on January 29 and will end today, January 31 The IPO price band is set at ₹382 to ₹402 per share.

Markets in Indian are poised to open with an upside, amid firm global cues, as investors track the start of the Budget ...

Kolkata: The West Bengal health dept asked a saline manufacturing unit, which is a major supplier to govt hospitals, to stop manufacturing the product.